Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic

Background: The use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is controversial for treating COVID-19 patients. We aimed to estimate pooled risks of mortality, disease severity, and hospitalization associated with ACEI/ARB use and stratify them by cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamer, Ahmad A., Almulhim, Abdulaziz S., Alrashed, Ahmed A., Abraham, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912160/
https://www.ncbi.nlm.nih.gov/pubmed/33525596
http://dx.doi.org/10.3390/healthcare9020127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912160/
https://www.ncbi.nlm.nih.gov/pubmed/33525596
http://dx.doi.org/10.3390/healthcare9020127

Ejemplares similares